INTRODUCTION
============

Poly(ADP-ribosyl)ation is a post-translational modification of proteins involved in cellular processes as diverse as DNA repair, transcription, cell division or cell death ([@B1]). Poly(ADP-ribose) (PAR) is rapidly produced at DNA breaks by the founding member of the PARP family PARP-1, triggering local chromatin relaxation ([@B2]) and recruitment of repair factors which have strong affinity for PAR, such as the base excision repair/single-strand break repair factor XRCC1 ([@B3; @B4; @B5; @B6]). The amount of PAR produced, which reflects the severity of the DNA insult, directly contributes to the cell decision to initiate either survival- or death- programmes ([@B7],[@B8]).

The PAR degrading enzyme poly(ADP-ribose) glycohydrolase (PARG) is encoded by a single gene but is present as multiple isoforms localized to different cellular compartments: full-length PARG^111^ is nuclear, PARG^102^ and PARG^99^ are cytoplasmic, whereas shorter isoforms (PARG^60^, PARG^55^) are targeted to the mitochondria ([@B9; @B10; @B11; @B12]). In mice, depleting all PARG isoforms is embryonically lethal, whereas a hypomorphic mutant is viable, but the mice are sensitive towards ionizing radiation and alkylating agents ([@B13],[@B14]). Using shRNA to prevent the expression of all PARG isoforms in cells, we and others have shown that PARG is required for efficient repair of single- and double-strand breaks and oxidized bases ([@B15; @B16; @B17]).

Using a combination of live-cell microscopy and laser microirradiation, we and others could demonstrate the rapid recruitment of PARP-1 and XRCC1 to DNA damage sites and the role of PARP-1 activity in these protein relocalizations ([@B4],[@B18],[@B19]). Here, we show that all PARG isoforms except for the mitochondrial localized PARG fragment could be efficiently recruited to DNA damage sites. The recruitment of PARG was only partially dependent on PARP-1 and PAR synthesis. We identified a functional PCNA-binding motif within the PARG sequence and showed that binding to PCNA contributes to PARG recruitment at sites of DNA damage. Our results reveal that PARG is recruited to DNA damage sites via at least two pathways, one is PAR-dependent and the other is PCNA-dependent.

MATERIAL AND METHODS
====================

Cell culture and transfection
-----------------------------

Wild type, PARP-1^−/−^ MEFs, PARP-2^−/−^ MEFs, HeLa, HEK293T and U2OS (clone 2-6-3) cells were cultured in DMEM supplemented with 10% FCS and 50 µg/ml gentamicin. Cells grown on µ-slides (ibidi) or on gridded coverslips were cotransfected with polyethylenimine (Sigma). For microirradiation experiments cells were sensitized by incubation in medium containing BrdU (10 µg/ml) for 24--48 h. NU1025 (Sigma) was added to the cells 1 h before microirradiation at a concentration of 200 µM. For GFP-pulldown analyses, cells grown on Petri dishes were transfected with JetPEI (Polyplus).

Expression plasmids
-------------------

The cDNA fragments encoding wild type and mutant human PARG were generated by PCR and subcloned into the *Eco*RI/*Sma*I sites of pEGFP-N1 (Clontech). Sequences of oligonuclotides and plasmids are available upon request. GFP-XRCC1, GFP-PARP-1, RFP-PCNA and PCNA-LacI-RFP expression construct were previously described ([@B4],[@B20]).

Live-cell microscopy, microirradiation and photobleaching experiments
---------------------------------------------------------------------

Live cell imaging, microirradiation and photobleaching experiments were carried out with a Leica TCS SP2/AOBS or Leica SP5/AOBS confocal laser scanning microscope, each equipped with a UV-transmitting HCX PL 63×/1.4 oil objective. GFP and RFP were excited with a 488 nm Ar laser line and a 561 nm DPSS laser line, respectively. The microscopes were equipped with a heated environmental chamber set to 37°C. Confocal image series were typically recorded with a frame size of 256 × 256 pixels and a pixel size of 90 nm.

Microirradiation was carried out as previously described ([@B21]). In brief, a preselected spot of ∼1 µm in diameter within the nucleus was microirradiated for 1 s with a 405 nm diode laser set to 50--80 µW. The laser power was measured after passing through the objective lens with a laser power meter (Coherent). Before and after microirradiation confocal image series of one mid *z*-section were recorded at 2 s time interval (typically six pre-irradiation and 150 post-irradiation frames). For evaluation of the recruitment kinetics, fluorescence intensities at the irradiated region were corrected for background and for total nuclear loss of fluorescence over the time course and normalized to the pre-irradiation value.

For FRAP analysis, a region of interest was selected and photobleached for 300 ms with all laser lines of the Ar-laser and the 561 nm DPSS laser set to maximum power at 100% transmission. Before and after bleaching, confocal image series were recorded at 150 ms time intervals (typically 10 pre-bleach and 200 post-bleach frames). Mean fluorescence intensities of the bleached region were corrected for background and for total nuclear loss of fluorescence over the time course and normalized to the mean of the last four prebleach values.

For the quantitative evaluation of microirradiation and photobleaching experiments, data of at least nine nuclei were averaged and the mean curve and the standard error of the mean calculated and displayed using Microsoft Excel software.

Indirect immunofluorescence microscopy
--------------------------------------

Cells grown on glass coverslips were treated as described in the legends of the figures, and fixed with ice cold methanol/acetone for 15 min (for PAR) or in ice-cold methanol for 5 min (for PCNA). Cells were permeabilized with PBS, 0.1% tween and incubated overnight at 4°C with primary antibodies diluted in PBS, 0.1% tween, 1 mg/ml BSA: mouse monoclonals anti-PAR 10H (IgG3k, 1:1000), anti-GFP (IgG1, 1:500, Roche) or anti-PCNA (IgG2a, 1:200, Dianova). Secondary antibodies used were Alexa Fluor goat anti-mouse IgG3 (568) or IgG1 (488 or 568) (1:2000, Molecular Probes, Invitrogen). Cells were counterstained with DAPI, mounted using Mowiol (Roche) and observed on a Leica DMRA2 equipped with an Orca-ER CCD camera (Hammamatsu) and the capture software OpenLab 4.1 (Improvision). Alternatively images were taken with a PerkinElmer UltraView Vox spinning disk microscope equipped with a Plan-Apochromat 63× /1.4 oil objective using Volocity software 5.0 for image capturing. DAPI, GFP and RFP were excited with a 405, 488 and a 561 nm DPSS laser line, respectively.

Zymogram
--------

PARG activity gel assay was performed as described by Amé *et al*. ([@B15]).

PAR-blot
--------

^32^P-labelled PAR was synthetised and purified as described by Amé *et al*. ([@B22]). PCNA (ENZO Life), histone H1 (ENZO Life) and BSA (Sigma) purified recombinant proteins were spotted onto nitrocellulose sheet as indicated in the figure, and the membrane was incubated with ^32^P-labelled PAR for 1.5 h at 25°C. After six washes of 10 min in PBS, the membrane was autoradiographied. Similar amounts of purified proteins were analysed by SDS--PAGE gel electrophoresis followed by Coomassie staining to verify the integrity and quantities of proteins used in the assay.

GFP-pull down assays
--------------------

HEK393T cells (1.5 × 10^7^) were transfected with the plasmids encoding GFP-tagged PARG as described in figure legend. Thirty-six hours post-transfection, cells were lysed in 20 mM Tris--HCl pH 7.5, 120 mM NaCl, 0.1% NP40, 0.5 mM Pefabloc and miniCOmplete protease inhibitor cocktail (Roche Diagnostic) for 20 min on ice, centrifuged at 132 000 rpm for 20 min at +4°C and supernatant was recovered. For the experiments including H~2~O~2~ treatment, cells were treated for 10 min with 1 mM H~2~O~2~ in complete medium at 37°C, washed twice with 1× PBS, pelleted and resuspended in 300 µl of 20 mM Tris--HCl pH 7.5, 400 mM NaCl, 5 mM DTT, 0.1% NP40, 20% glycerol, 0.5 mM Pefabloc and protease inhibitor. After four cycles of freeze/thaw and centrifugation at 132 000 rpm for 20 min at +4°C, supernatant was dilute to reach a final concentrention of NaCl of 120 mM. Protein extracts were incubated 2.5 h at +4°C with GFP-binder (Chromotek) on a rotating wheel. After four washes with 20 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.1% NP40, 0.5 mM Pefabloc, the immunoprecipitated proteins were solubilized in Laemmli buffer by boiling 4 min at 95°C and analysed by SDS--PAGE electrophoresis followed by western blotting. The membranes were probed with anti PCNA (PC10, DAKO, 1/1000) then with anti-GFP (Roche, 1/1000) monoclonal antibodies.

RESULTS AND DISCUSSION
======================

Except the mitochondrial PARG, all PARG isoforms are recruited to laser-induced DNA damage sites
------------------------------------------------------------------------------------------------

To follow the redistribution of GFP-tagged PARG to sites of DNA damage in living cells, we generated DNA lesions at preselected subnuclear sites in HeLa cells using laser microirradiation as previously described ([@B4],[@B21]). We found that PARG^111^-GFP ([Figure 1](#F1){ref-type="fig"}A) was recruited to DNA damage sites ([Figure 1](#F1){ref-type="fig"}B and C), but more slowly (maximum accumulation reached in more than 4 min) than two other central repair proteins GFP-PARP-1 and GFP-XRCC1 \[[Figure 1](#F1){ref-type="fig"}D and E and Mortusewicz *et al*. ([@B4])\]. Comparable recruitment kinetics of PARG^111^-GFP could be observed in immortalized mouse embryonic fibroblasts (MEF, [Figure 1](#F1){ref-type="fig"}F). The cytoplasmic isoforms PARG^102^ and PARG^99^ were shown previously to shuttle between the cytoplasm and the nucleus, and to accumulate in the nucleus following γ-irradiation ([@B23]). Here, we could show that both isoforms were recruited with similar kinetics ([Figure 1](#F1){ref-type="fig"}G and H) but accumulated less than PARG^111^-GFP (maximal intensity reached, MAX Int, reflecting the amount of protein accumulated, was 1.47 ± 0.07 for PARG^102^-GFP and 1.38 ± 0.04 for PARG^99^-GFP compared to 2.22 ± 0.11 for PARG^111^-GFP, [Supplementary Figure S1C and D](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). In contrast, PARG^461-976^-GFP, which corresponds to the previously described hPARG59 containing the regulatory segment and the mitochondrial localization signal ([@B11],[@B12],[@B24]), and thus localized to the mitochondria, was never recruited ([Figure 1](#F1){ref-type="fig"}I). To summarize, PARG^111^ and to a lesser extend PARG^102^ and PARG^99^ but not mitochondrial PARG^461--976^ accumulate at DNA damage sites *in vivo*. Figure 1.Recruitment of PARG isoforms to laser-induced DNA damage sites. (**A**) Schematic representation of PARG and fusion proteins used. (**B**) Live cell imaging of a microirradiated HeLa cell expressing PARG^111^-GFP. Comparision of PARG^111^-GFP (**C**), GFP-PARP-1 (**D**) and GFP-XRCC1 (**E**) recruitment to DNA damage sites in HeLa cells and quantitative evaluation of recruitment kinetics showing mean curves. Recruitment of the PARG isoforms PARG^111^-GFP (**F**), PARG^102^-GFP (**G**) and PARG^99^-GFP (**H**) to laser-induced DNA damage sites in mouse embryonic fibroblasts (MEFs). (**I**) The mitochondrial isoform PARG^461-976^-GFP shows no accumulation at microirradiated sites. Where no recruitment can be observed, sites of irradiation are indicated by arrows. Error bars represent the standard error of the mean. Scale bar: 5 µm.

Recruitment of PARG to DNA damage sites depends partly on PAR synthesis
-----------------------------------------------------------------------

We next examined whether the recruitment of PARG was dependent on PAR synthesized at DNA damage sites. Treatment of MEFs with the PARP inhibitor NU1025 or KU0058948 (data not shown) slowed down (time required for 50% of the maximum accumulation, tMAX1/2, of 72.51 ± 4.25 s, compared to 54.11 ± 3.03 s in absence of NU1025) and decreased the amount of PARG^111^-GFP recruited to DNA damage sites (MAX Int of 1.81 ± 0.09, compared to 2.11 ± 0.11 in absence of NU1025, [Figure 2](#F2){ref-type="fig"}B and C and [Supplementary Figure S1C and D](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). This indicates that the recruitment of PARG^111^-GFP depends partly on PAR synthesized at the damage site. However, it is apparently independent of PARP-1 or PARP-2, since PARG^111^-GFP recruitment is not affected in MEFs either lacking PARP-1 (*Parp-1*^−/−^, [Figure 2](#F2){ref-type="fig"}B and C) or PARP-2 (*Parp-2*^−/−^, [Supplementary Figure S1A and B](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). By examining the mobility of PARG molecules accumulated at DNA damage sites by FRAP analyses, we found a minor increase of PARG^111^-GFP mobility in the presence of the PARP inhibitor, indicating a reduced binding of PARG^111^-GFP to DNA damage sites, which could account to some extent for the different recruitment kinetics in the presence or absence of the PARP inhibitor ([Figure 2](#F2){ref-type="fig"}D). Altogether, these results indicate that the recruitment of PARG only partially depends on PAR synthesis, and point to the existence of a PAR-independent recruitment mechanism. Figure 2.PAR-dependent recruitment of PARG to DNA damage sites. (**A**) Schematic representation of PARG and fusion proteins used. (**B**) Live cell imaging of PARG^111^-GFP recruitment in wt MEFs (upper row), Parp-1^−/−^ MEFs (middle row) and in wt MEFs treated with the PARP inhibitor NU1025 (lower row). (**C**) Comparison of PARG^111^-GFP recruitment kinetics in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve). (**D**) Quantitative evaluation of FRAP data showing mean curves. To analyse the mobility of PARG^111^-GFP at DNA damage sites in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve) the microirradiated region was bleached 5 min after microirradiation and the fluorescence recovery was measured. (**E**) Accumulation of the N-terminal domain of PARG (PARG^1--469^-GFP) at laser-induced DNA damage sites. (**F**) Quantitative evaluation of PARG^1--469^-GFP recruitment kinetics in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve) showing mean curves. (**G**) The C-terminal domain of PARG (PARG^478--976^-GFP) shows no accumulation at DNA damage sites. Where no recruitment can be observed, sites of irradiation are indicated by arrows. Error bars represent the standard error of the mean. Scale bar: 5 µm.

We next aimed to unravel these PAR-dependent and PAR-independent mechanisms for PARG recruitment to DNA damage sites by analysing the recruitment of different PARG domains. Whereas the C-terminal half of PARG (PARG^478--976^-GFP) was not recruited ([Figure 2](#F2){ref-type="fig"}G), the N-terminal half of PARG (PARG^1-469^-GFP) considered to act as a putative regulatory domain ([Figure 2](#F2){ref-type="fig"}A) was efficiently recruited to DNA lesions, but its recruitment was independent of PARP-1 and PAR ([Figure 2](#F2){ref-type="fig"}E and F). This suggests that a sequence motif or a domain present in the N-terminal part mediates the PAR-independent recruitment, whereas the presence of the C-terminal part of PARG containing the catalytic domain probably confers PAR-dependent recruitment.

PARG catalytic activity regulates PARG localization to DNA damage sites
-----------------------------------------------------------------------

To assess whether PARG activity could influence its relocalization to DNA damage sites, we followed the recruitment of an inactive PARG, obtained by mutating glutamic acids 755 and 756 to alanines ([Figure 3](#F3){ref-type="fig"}A), according to Patel *et al*. ([@B25]). Inactivity of this mutant was verified by zymogram ([Figure 3](#F3){ref-type="fig"}B). PARG^E755,756A^-GFP showed a remarkable faster recruitment to DNA damage sites than its wild-type counterpart ([Figure 3](#F3){ref-type="fig"}C and 3D, compare the green and black curves and see [Supplementary Figure S1C and D](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). Interestingly, its recruitment was affected in *Parp-1*^−/−^ cells, but even more dramatically in the presence of a PARP inhibitor ([Figure 3](#F3){ref-type="fig"}C and D, compare the green, red and blue curves and [Supplementary Figure S1C and D](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). The dramatic decrease of PARG^E755,756A^-GFP recruitment in presence of a PARP inhibitor can be partially attributed to an increase of mobility, as shown by FRAP analyses ([Figure 3](#F3){ref-type="fig"}E), which indicates a weaker binding of PARG^E755,756A^-GFP to DNA damage sites in the absence of PAR. These results reveal the involvement of PARP-1 and PAR in the recruitment of PARG^111^. The slower recruitment kinetics of PARG^E755,756A^-GFP in cells treated with a PARP inhibitor than in cells lacking PARP-1 could result from the presence of inactive PARP-1 molecules at the damage site that could hamper the recruitment of PARG to the site of lesion. This hypothesis is strengthened by the slightly more efficient recruitment of PARG^E755,756A^-GFP in *Parp-1*^−/−^ MEFs treated with NU1025 than in wt MEFs treated with the same PARP inhibitor ([Figure 3](#F3){ref-type="fig"}D and data not shown). Of note, the residual recruitment of PARG^E755,756A^-GFP in the presence of a PARP inhibitor was comparable to that of wild-type PARG^111^-GFP in similar conditions (compare [Figures 3](#F3){ref-type="fig"}D and [2](#F2){ref-type="fig"}E), confirming the existence of a PAR-independent mechanism. Taken together, these results highlight the important role of PAR in the recruitment of PARG to DNA damage sites. Figure 3.Inactive PARG is recruited with higher efficiency to laser-induced DNA damage sites. (**A**) Schematic representation of PARG and PARG^E755,756A^-GFP. Mutated amino acid positions are indicated in red. (**B**) Zymogram showing the PAR-degrading capacity of the indicated GFP-tagged PARG proteins. (**C**) Live cell imaging of PARG^E755,756A^-GFP recruitment in wt MEFs (upper row), Parp-1^−/−^ MEFs (middle row) and in wt MEFs treated with the PARP inhibitor NU1025 (lower row). (**D**) Recruitment kinetics of PARG^E755,756A^-GFP in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated (blue curve) or not (black curves) with NU1025. (**E**) Mobility of PARG^E755,756A^-GFP at DNA damage sites in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve). (**F**) Immunodetection of PAR in PARG^KD^ cells expressing shRNA-insensitive PARG^E755,756A^-GFP or PARG^111^-GFP, at the time indicated after 10 min of treatment with 0.5 mM H~2~O~2~. Error bars represent the standard error of the mean. Scale bar: 5 µm.

The dramatic differences in the recruitment of PARG^E755,756A^-GFP and PARG^111^-GFP suggest that the catalytic activity of PARG^111^-GFP could affect its accumulation at DNA damage sites, by efficiently and promptly removing PAR produced in response to DNA damage. We tested this hypothesis by analysing the amount of PAR produced in H~2~O~2~-treated PARG^KD^ cells which lack endogenous PARG ([@B15]), transfected with plasmids encoding shRNA-insensitive PARG^E755,756A^-GFP or PARG^111^-GFP. PAR could be detected in H~2~O~2~-treated and untreated PARG^KD^ cells as previously shown ([@B15]) and also in cells expressing PARG^E755,756A^-GFP, whereas in cells expressing PARG^111^-GFP PAR could never be detected ([Figure 3](#F3){ref-type="fig"}F). Therefore, the fast PAR degradation at DNA damage sites observed in presence of an overexpressed active PARG masks the contribution of PARP-1/PAR in its recruitment, that can only be clearly revealed with the catalytically inactive PARG^E755,756A^-GFP. Taken together, our data suggest that there are several modes of PARG recruitment to DNA damage sites: one PARP-1/PAR dependent (represented by the shift of the green to the red curve in [Figure 3](#F3){ref-type="fig"}D), one PAR-dependent and possibly PARP-1 independent (red to blue curve in [Figure 3](#F3){ref-type="fig"}D), and one PAR-independent (blue curve to no recruitment in [Figure 3](#F3){ref-type="fig"}D) that we next aimed to analyse in more detail.

PARG interacts with PCNA through a PIP box-containing PBD
---------------------------------------------------------

In the course of our study, we noticed that PARG^111^-GFP displayed a punctuate localization in a fraction of cells, resembling replication foci. We could show that PARG^111^-GFP colocalizes with co-expressed RFP-PCNA or endogenous PCNA at each stage of S-phase ([Figure 4](#F4){ref-type="fig"}A and E), suggesting that PARG is present at the replication forks throughout S-phase. In contrast, PARG^102^-GFP and PARG^99^-GFP were never found to colocalize with PCNA at sites of replication (data not shown), suggesting that the first 1--83 residues of PARG are necessary for this localization to replication foci. In order to test whether PARG interacts with PCNA, we overexpressed GFP-tagged PARG isoforms in HEK293T cells and immunoprecipitated the protein complexes using anti-GFP-coupled beads. Copurifying endogenous PCNA was assessed by western blot ([Figure 4](#F4){ref-type="fig"}B). PCNA was efficiently copurified with the positive control GFP-DNMT1 ([@B26]), but not with GFP alone. PCNA also interacted with PARG^111^-GFP, but the interaction was dramatically decreased, although not completely abolished, with PARG^102^-GFP and PARG^99^-GFP. This demonstrates that PARG interacts with PCNA and that the very N-terminal part is involved in this interaction. This is further confirmed by the observed interaction of PCNA with PARG^1--469^-GFP, but not with PARG^461--976^-GFP and PARG^478--976^-GFP. Figure 4.PARG interacts with PCNA and is present at replication foci. (**A**) Colocalization of PARG with PCNA throughout S-phase. Spinning disk microscopy images of wt MEFs coexpressing PARG^111^-GFP and RFP-PCNA in different S-phase stages. PARG^111^-GFP colocalizes with RFP-PCNA at sites of replication throughout S-phase. (**B**) Interaction of PARG with PCNA analysed by GFP-pull down assays. The indicated GFP-tagged proteins were overexpressed in HEK293T cells, recovered by GFP-pulldown and copurified PCNA was assessed by western blot with anti PCNA antibodies (upper panels). The presence of GFP-tagged protein is revealed with an anti GFP antibody (lower panels). (**C**) Effect of H~2~O~2~ treatment on the interaction between PARG and PCNA. PARG^111^-GFP and PARG^E755,756A^-GFP overexpressing HEK293T cells were treated with 1 mM H~2~O~2~ for 10 min before performing a GFP-pull down assay as described in (B). The asterisk indicates mono-ubiquitinated PCNA, visible in the input of H~2~O~2~-treated cells (1% input was loaded on the gel). (**D**) Schematic representation of PARG including the identified PIP box sequence and fusion proteins used. Mutated amino acid positions are indicated in red. (**E**) Spinning disk microscopy images of wt MEFs expressing PARG^111^-GFP, PARG^Q76A^-GFP or PARG^Q76E^-GFP and stained with a mouse-monoclonal antibody against PCNA to mark sites of replication. (**F**) Effect of the mutation of the PARG PIP domain on its interaction with PCNA. GFP-pull down assays with the indicated PARG constructs were performed as in (B). (**G**) Schematic outline of the F2H assay (see text for details). (**H**) U2OS.2-6-3 cells with a stably integrated lac operator array coexpressing PCNA-LacI-RFP (bait protein) and various GFP-tagged PARG fusions (prey proteins). Colocalization of the red PCNA-LacI-RFP signal with a green prey signal at the lac operator array indicates interaction. (**I**) Quantification of the relative enrichment of PARG^111^-GFP, PARG^Q76A^-GFP, PARG^Q76E^-GFP and GFP at the lac operator array. For quantification, the fluorescence signal at the lac operator array was measured and divided by the overall fluorescence measured in the nucleus. Error bars represent the standard error of the mean. Scale bar: 5 µm.

We then tested whether the interaction between PARG and PCNA was modified in response to DNA damage. PCNA was co-immunoprecipitated with PARG-^111^-GFP with comparable efficiency whether cells were treated or not with 1 mM H~2~O~2~ for 10 min before lysis ([Figure 4](#F4){ref-type="fig"}C). However, since the overexpression of PARG-^111^-GFP alters the production of H~2~O~2~-triggered PAR synthesis as shown in [Figure 3](#F3){ref-type="fig"}F, we performed the same experiment with the inactive PARG^E755,756A^-GFP mutant. Whereas the mutation of PARG catalytic domain had no significant effect on binding to PCNA, the H~2~O~2~ treatment slightly decreased the interaction between the two proteins, suggesting that PARG activity can regulate this interaction in response to DNA damage. However, we do not want to conclude from these experiments that normal endogenous PARG and PCNA interact less in response to DNA damage, since overexpressing the inactive PARG mutant could also have repercussions on the PAR level of the damaged cells, by a dominant-negative effect. The only way to really test the potential DNA-damage dependent change in PARG-PCNA interaction would be to look at complexes formed by endogenous proteins, but the lack of specific anti PARG antibodies precludes from such experiments.

Carefull examination of the PARG primary sequence led us to identify a motif at the N-terminus resembling a PIP (PCNA-interacting-peptide) box, 76-QKTITSW-82, found in various PCNA binding domains (PBD) of replication and repair associated proteins ([@B27],[@B28]) ([Figure 4](#F4){ref-type="fig"}D). An N-terminal PARG construct encompassing this motif (PARG^1--87^-GFP, [Figure 4](#F4){ref-type="fig"}D) was able to bind PCNA, whereas a shorter construct ending just before this motif (PARG^1--75^-GFP) failed to bind PCNA, demonstrating the functionality of this sequence acting as a PIP box ([Figure 4](#F4){ref-type="fig"}B). Since the Gln residue Q76 has been shown to be essential for PCNA interaction through the PBD of several proteins ([@B28]), we mutated it to either Ala or Glu in PARG^111^-GFP ([Figure 4](#F4){ref-type="fig"}C). Both mutations impaired the localization of the proteins PARG^Q76A^-GFP and PARG^Q76E^-GFP at replication foci ([Figure 4](#F4){ref-type="fig"}E). However, when these mutants were tested for their interaction with PCNA by co-immunoprecipitation in HEK293T overexpressing cells, they both unexpectedly still showed strong binding to PCNA ([Figure 4](#F4){ref-type="fig"}F). This result does not fit with the lack of colocalization of these mutants with PCNA *in vivo*, as shown in [Figure 4](#F4){ref-type="fig"}E. We therefore propose that the interaction observed in the immunoprecipitation assays might result from interactions with third proteins that could reinforce the link between PCNA and these mutants. Alternatively, we cannot exclude that another domain of PARG participates in the interaction with PCNA. This hypothesis is strengthened by the residual binding observed for PARG^102^-GFP to PCNA ([Figure 4](#F4){ref-type="fig"}B). To further test the interaction of PARG and its PIP mutants with PCNA *in vivo*, we used a fluorescent two-hybrid assay developed for the direct visualization of protein--protein interactions in living cells ([@B20]). Briefly, the fluorescent bait, consisting of PCNA fused to LacI and RFP is tethered to a stably integrated chromosomal lac operator array in the nucleus and interaction is assayed for by looking for co-localization with GFP-tagged prey proteins at this defined spot ([Figure 4](#F4){ref-type="fig"}G). Using this technique, we could show that PARG^111^-GFP interacts with PCNA-LacI-RFP *in vivo*, whereas GFP did not ([Figure 4](#F4){ref-type="fig"}H). Introducing a point mutation at the conserved Gln residue within the PIP box strongly impaired the interaction of PARG^Q76A^-GFP or PARG^Q76E^-GFP with PCNA-LacI-RFP, without completely abolishing it, as shown by the quantitative evaluation of the enrichment of these proteins at the lac operator array ([Figure 4](#F4){ref-type="fig"}H and I). Taken together, these results demonstrate that PARG interacts with PCNA and that the PIP domain is involved in this interaction *in vivo*.

PARG interaction with PCNA favours its recruitment to DNA damage sites
----------------------------------------------------------------------

Besides its essential implication in DNA replication, PCNA is also an active player in various repair pathways, such as mismatch repair, nucleotide excision repair and base excision repair \[see for review ref. ([@B27],[@B29])\]. As such, PCNA is recruited to locally introduced DNA damage ([@B5],[@B18],[@B19],[@B30; @B31; @B32]), although not as fast as the scaffold BER protein XRCC1 ([@B4]). We thus wondered whether the interaction of PARG with PCNA could regulate the dynamics of PARG at DNA damage sites.

We compared the recruitment of the PIP-bearing fusion protein PARG^1-87^-GFP with that of the PIP-lacking fusion protein PARG^1--75^-GFP to laser-induced DNA damage sites. In contrast to PARG^1--75^-GFP, PARG^1--87^-GFP was recruited to DNA damage sites, although with low efficiency ([Figure 5](#F5){ref-type="fig"}A and B), indicating that PARG can also be recruited to DNA damage sites via its interaction with PCNA. We then examined the recruitment of full length PARG harbouring a mutation in the PIP box. The Q76A (or Q76E, data not shown) mutation diminished the recruitment of PARG at DNA lesions introduced in wild-type MEFs ([Figure 5](#F5){ref-type="fig"}C and [Supplementary Figure S1E](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1) and F, MAX Int of 1.77 ± 0.05 for PARG^Q76A^-GFP compared to 2.22 ± 0.11 s for PARG^111^-GFP). These results support the involvement of PCNA in the efficient recruitment of PARG to DNA damage sites. Moreover, recruitment of PARG^Q76A^-GFP was decreased upon PARP inhibition or in *Parp-1*^−/−^ cells ([Figure 5](#F5){ref-type="fig"}C), though not totally abolished, pointing to the existence of an additional mechanism for PARG recruitment to DNA damage sites that is PCNA- and PAR-independent. Of note, the accumulation of PARG^Q76A^-GFP (or PARG^Q76E^-GFP, data not shown) in the presence of a PARP inhibitor was only slightly more affected than that of wild-type PARG^111^-GFP in the same condition ([Figure 5](#F5){ref-type="fig"}D and [Supplementary Figure S1F](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1), MAX Int of 1.67 ± 0.09 for PARG^Q76A^-GFP in the presence of NU1025 compared to 1.81 ± 0.09 for PARG^111^-GFP in the presence of NU1025). These results suggest that the PCNA-mediated recruitment of PARG could partly depend itself on PAR. This is further supported by the fact that PARG^1--87^-GFP accumulates more slowly in *Parp-1*^−/−^ cells or in the presence of NU1025, whereas PARG^1--75^-GFP is not recruited at all in any condition ([Figure 5](#F5){ref-type="fig"}A). Indeed, that PARP-1 inhibition could partially decrease PCNA relocalization to DNA damage sites was reported previously by Okano *et al*. ([@B5]) and Lan *et al*. ([@B18]), whereas Godon *et al*. ([@B18]) made the opposite observation of an increased accumulation of PCNA at microirradiated sites upon chemical inhibition of PARPs, but not in cells lacking PARP-1. These contradictory data prompted us to look at the recruitment of PCNA in our experimental system. We found that recruitment of Cherry-PCNA at laser-induced DNA damages was hindered by PARP inhibition, but not in *Parp-1^−/−^* cells ([Figure 5](#F5){ref-type="fig"}E and F and [Supplementary Figure SIE and F](http://nar.oxfordjournals.org/cgi/content/full/gkr099/DC1)). This reminds what we observed for PARG^111^ and PARG^E755,756A^ which were both recruited less efficiently upon PARP inhibition than in the absence of PARP-1 ([Figures 2](#F2){ref-type="fig"}C and [3](#F3){ref-type="fig"}C). Moreover, the NU1025 PARP inhibitor impedes more severely the recruitment of PARG^E755,756A^-GFP in *Parp-1^+/+^* cells than it did in *Parp-1^−/−^* cells, supporting the hypothesis that it is the presence of inactive PARP-1 molecules that likely affects the access of PCNA and PARG to DNA damage sites. In addition, we failed to show a direct interaction of recombinant PCNA with purified PAR on dot blot assays ([Figure 5](#F5){ref-type="fig"}G), supporting the fact that PCNA recruitment to DNA damage sites unlikely depends on a direct binding to PAR. Figure 5.PARG interaction with PCNA contributes to its accumulation at laser-induced DNA damage sites. (**A**) Accumulation and recruitment kinetics of PARG^1-87^-GFP to laser-induced DNA damage sites. The recruitment kinetics of PARG^1-87^-GFP in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve) as well as the recruitment kinetics for PARG^111^-GFP in wt MEFs (light green) are shown for comparison. (**B**) PARG^1-75^-GFP lacking the newly identified PIP box does not accumulate at DNA damage sites. (**C**) Mutation of the newly identified PIP box of PARG (PARG^Q76A^-GFP) decreases PARG accumulation to DNA damage sites. Recruitment kinetics of PARG^Q76A^-GFP in wt MEFs (green curve), Parp-1^−/−^ MEFs (red curve) and wt MEFs treated with NU1025 (blue curve) as well as the recruitment kinetics for PARG^111^-GFP in wt MEFs (light green) are shown for comparison. (**D**) Comparison of PARG^Q76A^-GFP (dark blue curve) and PARG^111^-GFP (light blue curve) recruitment kinetics in wt MEFs treated with NU1025. Error bars represent the standard error of the mean. Scale bar: 5 µm. (**E**) Live cell imaging of cherry-PCNA recruitment in wt MEFs (upper row), Parp-1^−/−^ MEFs (middle row) and in wt MEFs treated with the PARP inhibitor NU1025 (lower row). (**F**) Comparison of cherry-PCNA recruitment kinetics in wt MEFs (red curve), Parp-1^−/−^ MEFs (blue curve) and wt MEFs treated with NU1025 (green curve). Error bars represent the standard error of the mean. Where no recruitment can be observed, sites of irradiation are indicated by arrows. Scale bar: 5 µm. (**G**) PCNA does not bind PAR on polymer blot assay. Recombinant purified BSA, histone H1 and PCNA were spotted on nitrocellulose membrane as indicated before incubation with ^32^P-labelled PAR (right panel). Same amounts of proteins were analysed by SDS--PAGE gel electrophoresis and Coomassie staining to control the quality and quantities of the proteins used in the assay.

In summary, in this study we identified two modes of recruitment for PARG to DNA damage sites. Given the importance of PARG in the cellular response to DNA damage through the regulation of PAR levels, it was tempting to speculate that PARG might be targeted to DNA damage sites by direct recognition of PARylated proteins, like histones or PARP-1. We found that both PAR and PARP-1 actually have an influence on PARG recruitment, probably either by enabling PARG access to the damage sites by the local opening of chromatin or by serving as a docking site for PARG recruitment. Besides, we could identify a second and unexpected mode of recruitment through a PBD-mediated interaction of PARG with PCNA. This newly identified interaction of PARG with PCNA could have evolved to enhance the recruitment efficiency of PARG to DNA damage sites. As PCNA shows a slow and constant accumulation at DNA damage sites and also remains associated with repair sites for a prolonged period of time, this interaction could also ensure that PAR levels are kept low at later steps of repair via the constant recruitment of PARG. Alternatively, and considering that (i) PCNA is involved in the long-patch BER pathway ([@B33]), (ii) PARP-1 participates in the decision between short- and long-patch BER ([@B34]), (iii) PARG interacts with PARP-1 and XRCC1 ([@B35]) and PCNA (this study) and (iv) PAR is proposed to be a source of energy favouring long-patch repair in conditions of ATP shortage ([@B36]), the PCNA-dependent accumulation of PARG at DNA damage sites identified here could also be regarded as an additional regulatory level for long-patch base BER.
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